Savings in space, time and profits are just a few of the things cellular manufacturing concepts have going for them. Last month I presented an introduction to work cells by looking back at how ...

Cellular manufacturing systems (CMS) represent a pivotal approach to modern industrial production, in which machines and workstations are organised into discrete cells dedicated to the manufacture of ...

Cellular Origins is a UK‑based company enabling scalable, factory‑led automation for cell and gene therapy manufacturing, and ...

This is a preview. Log in through your library . Abstract This paper is both an extension and an expansion of two earlier studies concerned with the direction of OR/MS research as reported in its ...

A study led by the School of Engineering of the Hong Kong University of Science and Technology (HKUST) has developed an innovative method that overcomes the limitations of traditional additive ...

Cellular Origins, a TTP company, acquired the ACTIA (Autologous Cell Therapy Industrial Automation) Platform IP, developed by Geoff Hodge while CEO of SOTIO Biotech US. The ACTIA Platform complements ...

Cellular Origins, a company that enables the manufacturing of cell therapies at scale, has completed a $40 million ...

Cellular and gene therapy fields are currently on track for, if not already experiencing, a serious capacity crunch. Current cellular and gene therapies, those relatively few marketed and the hundreds ...

Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), has today announced a collaborative partnership with ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...